Dose Selection for Paltusotine, a Once Daily Oral Nonpeptide, Somatostatin Receptor 2 Ligand, for the Treatment of PatientsWith Carcinoid Syndrome (CS)Hjalmar Lagast,Ajay Madan,David C. Metz,Rosa Luo,Scott R. Struthers,Alan KrasnerPANCREAS（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
